Abstract

Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors
Xiaoying Fu ... Yimeng Gao
Blood | VOL. 134
Xiaoying Fu, et. al.Xiaoying Fu ... Yimeng Gao
13 Nov 2019
Abstract SY16-01: What IDH mouse models have taught us about hematological diseases, from leukemia to T cell lymphoma
Julie Leca
Cancer Research | VOL. 84
Julie LecaJulie Leca
05 Apr 2024
Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)
Alexandra R Grassian ... Raymond Pagliarini
Journal of Biological Chemistry | VOL. 287
Alexandra R Grassian, et. al.Alexandra R Grassian ... Raymond Pagliarini
01 Dec 2012
Updated Survival and Response Analyses from a Phase 1 Study of Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation
Mikhail Roshal ...
Blood | VOL. 138
Mikhail Roshal, et. al.Mikhail Roshal ...
05 Nov 2021
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Richard Allen ... Huzefa Bahrain
American journal of hematology | VOL. 99
Richard Allen, et. al.Richard Allen ... Huzefa Bahrain
01 Jun 2024
-
-
American Journal of Hematology | VOL. 99
--
01 Jun 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Matthew Mei
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Matthew Mei
28 May 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Paul Koller
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Paul Koller
27 May 2024
View more papers